Meta-analysis of 18 F-PSMA-1007 PET/CT, 18 F-FDG PET/CT, and 68Ga-PSMA PET/CT in diagnostic efficacy of prostate Cancer
Abstract Objective To compare 18 F-PSMA-1007 PET/CT, 18 F-FDG PET/CT and 68Ga-PSMA PET/CT in the diagnostic value of prostate cancer. Method The Chinese and foreign databases, such as Pubmed, Cochrane Library, Embase, CNKI, VIP, Wanfang, etc., were systematically searched within the period from the...
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2023-08-01
|
| Series: | Cancer Imaging |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s40644-023-00599-y |
| _version_ | 1797451694608482304 |
|---|---|
| author | Wenxiao Yu Ming Zhao Yingjun Deng Shengjing Liu Guanchao Du Bin Yan Ziwei Zhao Ning Sun Jun Guo |
| author_facet | Wenxiao Yu Ming Zhao Yingjun Deng Shengjing Liu Guanchao Du Bin Yan Ziwei Zhao Ning Sun Jun Guo |
| author_sort | Wenxiao Yu |
| collection | DOAJ |
| description | Abstract Objective To compare 18 F-PSMA-1007 PET/CT, 18 F-FDG PET/CT and 68Ga-PSMA PET/CT in the diagnostic value of prostate cancer. Method The Chinese and foreign databases, such as Pubmed, Cochrane Library, Embase, CNKI, VIP, Wanfang, etc., were systematically searched within the period from the establishment of the database to June 1, 2022. Clinical studies related to the diagnosis of prostate cancer by methods such as 18 F-PSMA-1007 PET/CT, 18 F-FDG PET/CTCT, 68Ga-PSMA PET/CT, were researched. Two (2) investigators independently screened literatures, extracted data, and assessed the risk of bias when these data were included in the studies with the Quality Assessment of Diagnostic Accuracy Studies (QUADAS-2). Review Manager5.4, Stata 14.0, and Meta-disc 1.4 software were used for meta-analysis to compare the efficacy of different methods in the diagnose of prostate cancer. Results Twenty-seven (27) studies, including 2891 subjects were included in our study. Meta-analysis results showed that the pooled sensitivities of 18 F-PSMA-1007 PET/CT, 18 F-FDG PET/CT, and 68Ga-PSMA PET/CT were 0.912 (95%CI: 0.883–0.936), 0.748 (95%CI: 0.698–0.795), and 0.916 (95%CI: 0.896–0.934), respectively; the pooled specification were 0.878 (0.844–0.907), 0.639 (95%CI: 0.589–0.687), and 0.734 (95%CI: 0.685–0.779), respectively; the positive likelihood ratios were 6.335 (95%CI: 4.288–9.357), 2.282 (95%CI: 1.497–3.477), and 3.593 (95%CI: 2.986–4.323), respectively; the negative likelihood ratios were 0.878 (95%CI: 0.844–0.907), 0.374 (95%CI: 0.280–0.499), and 0.110 (95%CI: 0.083–0.144), respectively; the diagnostic odds ratios were 65.125 (95%CI: 34.059–124.53), 7.094 (95%CI: 4.091–12.301), and 29.722 (95%CI: 20.141–43.863), respectively; the positive posterior probability was 64%, 38%, and 62%, respectively; the area under the SPOC curve was 0.95 (95%CI: 0.93–0.97), 0.81 (95%CI: 0.78–0.84), and 0.96 (95%CI: 0.92–0.98), respectively. The funnel plots indicated that there was no significant publication bias in the included literatures. Conclusion The current evidences showed that 18 F-PSMA-1007 PET/CT and 68Ga-PSMA PET/CT had higher diagnostic efficacy of prostate cancer compared with 18 F-FDG PET/CT, among which 68Ga-PSMA PET/CT was slightly higher in the sensitivity of the diagnosis of prostate cancer, while 18 F-PSMA-1007 PET/CT may have higher efficacy in specificity and confirmed positive rate. Due to the limitations of the quality of the included samples and literatures, the above conclusions should be further validated by expanding the sample size and improving the quality. |
| first_indexed | 2024-03-09T14:57:12Z |
| format | Article |
| id | doaj.art-7e43a443aefe474abaab6f735b86ef7f |
| institution | Directory Open Access Journal |
| issn | 1470-7330 |
| language | English |
| last_indexed | 2024-03-09T14:57:12Z |
| publishDate | 2023-08-01 |
| publisher | BMC |
| record_format | Article |
| series | Cancer Imaging |
| spelling | doaj.art-7e43a443aefe474abaab6f735b86ef7f2023-11-26T14:06:22ZengBMCCancer Imaging1470-73302023-08-0123111110.1186/s40644-023-00599-yMeta-analysis of 18 F-PSMA-1007 PET/CT, 18 F-FDG PET/CT, and 68Ga-PSMA PET/CT in diagnostic efficacy of prostate CancerWenxiao Yu0Ming Zhao1Yingjun Deng2Shengjing Liu3Guanchao Du4Bin Yan5Ziwei Zhao6Ning Sun7Jun Guo8Department of Andrology, Xiyuan Hospital of China Academy of Chinese Medical SciencesGraduate School, Beijing University of Chinese MedicineDepartment of Andrology, Xiyuan Hospital of China Academy of Chinese Medical SciencesDepartment of Andrology, Xiyuan Hospital of China Academy of Chinese Medical SciencesDepartment of Andrology, Xiyuan Hospital of China Academy of Chinese Medical SciencesDepartment of Andrology, Xiyuan Hospital of China Academy of Chinese Medical SciencesDepartment of Andrology, Xiyuan Hospital of China Academy of Chinese Medical SciencesPost-doctoral Research Station, Xiyuan Hospital of China Academy of Chinese Medical SciencesDepartment of Andrology, Xiyuan Hospital of China Academy of Chinese Medical SciencesAbstract Objective To compare 18 F-PSMA-1007 PET/CT, 18 F-FDG PET/CT and 68Ga-PSMA PET/CT in the diagnostic value of prostate cancer. Method The Chinese and foreign databases, such as Pubmed, Cochrane Library, Embase, CNKI, VIP, Wanfang, etc., were systematically searched within the period from the establishment of the database to June 1, 2022. Clinical studies related to the diagnosis of prostate cancer by methods such as 18 F-PSMA-1007 PET/CT, 18 F-FDG PET/CTCT, 68Ga-PSMA PET/CT, were researched. Two (2) investigators independently screened literatures, extracted data, and assessed the risk of bias when these data were included in the studies with the Quality Assessment of Diagnostic Accuracy Studies (QUADAS-2). Review Manager5.4, Stata 14.0, and Meta-disc 1.4 software were used for meta-analysis to compare the efficacy of different methods in the diagnose of prostate cancer. Results Twenty-seven (27) studies, including 2891 subjects were included in our study. Meta-analysis results showed that the pooled sensitivities of 18 F-PSMA-1007 PET/CT, 18 F-FDG PET/CT, and 68Ga-PSMA PET/CT were 0.912 (95%CI: 0.883–0.936), 0.748 (95%CI: 0.698–0.795), and 0.916 (95%CI: 0.896–0.934), respectively; the pooled specification were 0.878 (0.844–0.907), 0.639 (95%CI: 0.589–0.687), and 0.734 (95%CI: 0.685–0.779), respectively; the positive likelihood ratios were 6.335 (95%CI: 4.288–9.357), 2.282 (95%CI: 1.497–3.477), and 3.593 (95%CI: 2.986–4.323), respectively; the negative likelihood ratios were 0.878 (95%CI: 0.844–0.907), 0.374 (95%CI: 0.280–0.499), and 0.110 (95%CI: 0.083–0.144), respectively; the diagnostic odds ratios were 65.125 (95%CI: 34.059–124.53), 7.094 (95%CI: 4.091–12.301), and 29.722 (95%CI: 20.141–43.863), respectively; the positive posterior probability was 64%, 38%, and 62%, respectively; the area under the SPOC curve was 0.95 (95%CI: 0.93–0.97), 0.81 (95%CI: 0.78–0.84), and 0.96 (95%CI: 0.92–0.98), respectively. The funnel plots indicated that there was no significant publication bias in the included literatures. Conclusion The current evidences showed that 18 F-PSMA-1007 PET/CT and 68Ga-PSMA PET/CT had higher diagnostic efficacy of prostate cancer compared with 18 F-FDG PET/CT, among which 68Ga-PSMA PET/CT was slightly higher in the sensitivity of the diagnosis of prostate cancer, while 18 F-PSMA-1007 PET/CT may have higher efficacy in specificity and confirmed positive rate. Due to the limitations of the quality of the included samples and literatures, the above conclusions should be further validated by expanding the sample size and improving the quality.https://doi.org/10.1186/s40644-023-00599-yProstate cancerProstate-specific membrane antigenDiagnosisPET/CTRadioisotopesmeta-analysis |
| spellingShingle | Wenxiao Yu Ming Zhao Yingjun Deng Shengjing Liu Guanchao Du Bin Yan Ziwei Zhao Ning Sun Jun Guo Meta-analysis of 18 F-PSMA-1007 PET/CT, 18 F-FDG PET/CT, and 68Ga-PSMA PET/CT in diagnostic efficacy of prostate Cancer Cancer Imaging Prostate cancer Prostate-specific membrane antigen Diagnosis PET/CT Radioisotopes meta-analysis |
| title | Meta-analysis of 18 F-PSMA-1007 PET/CT, 18 F-FDG PET/CT, and 68Ga-PSMA PET/CT in diagnostic efficacy of prostate Cancer |
| title_full | Meta-analysis of 18 F-PSMA-1007 PET/CT, 18 F-FDG PET/CT, and 68Ga-PSMA PET/CT in diagnostic efficacy of prostate Cancer |
| title_fullStr | Meta-analysis of 18 F-PSMA-1007 PET/CT, 18 F-FDG PET/CT, and 68Ga-PSMA PET/CT in diagnostic efficacy of prostate Cancer |
| title_full_unstemmed | Meta-analysis of 18 F-PSMA-1007 PET/CT, 18 F-FDG PET/CT, and 68Ga-PSMA PET/CT in diagnostic efficacy of prostate Cancer |
| title_short | Meta-analysis of 18 F-PSMA-1007 PET/CT, 18 F-FDG PET/CT, and 68Ga-PSMA PET/CT in diagnostic efficacy of prostate Cancer |
| title_sort | meta analysis of 18 f psma 1007 pet ct 18 f fdg pet ct and 68ga psma pet ct in diagnostic efficacy of prostate cancer |
| topic | Prostate cancer Prostate-specific membrane antigen Diagnosis PET/CT Radioisotopes meta-analysis |
| url | https://doi.org/10.1186/s40644-023-00599-y |
| work_keys_str_mv | AT wenxiaoyu metaanalysisof18fpsma1007petct18ffdgpetctand68gapsmapetctindiagnosticefficacyofprostatecancer AT mingzhao metaanalysisof18fpsma1007petct18ffdgpetctand68gapsmapetctindiagnosticefficacyofprostatecancer AT yingjundeng metaanalysisof18fpsma1007petct18ffdgpetctand68gapsmapetctindiagnosticefficacyofprostatecancer AT shengjingliu metaanalysisof18fpsma1007petct18ffdgpetctand68gapsmapetctindiagnosticefficacyofprostatecancer AT guanchaodu metaanalysisof18fpsma1007petct18ffdgpetctand68gapsmapetctindiagnosticefficacyofprostatecancer AT binyan metaanalysisof18fpsma1007petct18ffdgpetctand68gapsmapetctindiagnosticefficacyofprostatecancer AT ziweizhao metaanalysisof18fpsma1007petct18ffdgpetctand68gapsmapetctindiagnosticefficacyofprostatecancer AT ningsun metaanalysisof18fpsma1007petct18ffdgpetctand68gapsmapetctindiagnosticefficacyofprostatecancer AT junguo metaanalysisof18fpsma1007petct18ffdgpetctand68gapsmapetctindiagnosticefficacyofprostatecancer |